StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SZLS

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Jul 12, 2021 3:21am

136 Views

Post# 33528723

RE:RE:RE:RE:RE:RE:SZLS

Hey, dum-dum, SZLS stated repeatedly that Care Oncology were getting first dibs at Aristotle before it was launched to the wider market.
So, that means that existing patients in the U.S. and U.K. have been tested, which is consistent with Tripp's assertion in interview, and with Rebecca's surprise at the low estimate of this year's sales by our eResearch analyst.
This has all been mentioned several times before - it makes your efforts to obscure or muddy these facts look like gaslighting.

Liked2Think wrote: Maybe a better question since I am labeled as dumb but the pumpers have been telling everyone to buy since it was still above a dollar are the geniuses.

Why is it only available in California and why only now seeing how Aristotle was "launched" in April? Thats proof Aristotle wasnt launched in April so chalk that up to yet another lie we were fed.

its telehealth. Why isnt it launching anywhere else now this time for real? Wouldnt they at least "launch" it in california and Virginia?

you people that blindly trust everything with this company even after it has lost over 70% of its value is unbelievable.